Cite
Nashabat M, Al-Khenaizan S, Alfadhel M. Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations. Ther Clin Risk Manag. 2018;14:225-229doi: 10.2147/TCRM.S151732.
Nashabat, M., Al-Khenaizan, S., & Alfadhel, M. (2018). Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations. Therapeutics and clinical risk management, 14225-229. https://doi.org/10.2147/TCRM.S151732
Nashabat, Marwan, et al. "Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations." Therapeutics and clinical risk management vol. 14 (2018): 225-229. doi: https://doi.org/10.2147/TCRM.S151732
Nashabat M, Al-Khenaizan S, Alfadhel M. Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations. Ther Clin Risk Manag. 2018 Feb 02;14:225-229. doi: 10.2147/TCRM.S151732. eCollection 2018. PMID: 29440907; PMCID: PMC5798556.
Copy
Download .nbib